ANLON HEALTHCARE LIMITED
Price Band
₹ 86 - ₹ 91
Bid Lot
164 Shares
ANLON HEALTHCARE LIMITED
26-Aug-2025 - 29-Aug-2025
Price Band
₹ 86 - ₹ 91
Minimum Investment
₹ 14924.00
Bid Lot
164 Shares
Shares
13,300,000
-
Face Value - Rs. 10/- Per Share
- Lisitng at BSE, NSE
-
8,109 Application Required in Retail for 1 Time.
-
Registrar :
KFin Technologies Limited
IPO Details
QIB
75%
(9,975,000 Shares)RS.90.77 CR
HNI 1
5%
(665,000 Shares)RS.6.05 CR @ 290 FORM 1X
HNI 2
10%
(1,330,000 Shares)RS.12.10 CR @ 579 FORM 1X
Retail
10%
(1,330,000 Shares)RS.12.10 CR @ 8110 FORM 1X
Timeline
-
26
Aug-2025
Open Date
-
29
Aug-2025
Close Date
-
01
Sep-2025
Basis of Allotment Date
-
02
Sep-2025
Initiation of Refunds
-
02
Sep-2025
Credit of Shares to Demat A/C
-
03
Sep-2025
IPO Listing Date
Subscription as on 29-Aug-2025 17:08
Category
Book Size
Subscription
QIB
2.68x
3,990,000
(₹36.31 Cr.)
10,689,028
(₹97.27 Cr.)
HNI (<10 LAKH)
16.69x
665,000
(₹6.05 Cr.)
11,101,488
(₹101.02 Cr.)
HNI2 (>10 LAKH)
7.56x
1,330,000
(₹12.10 Cr.)
10,059,924
(₹91.55 Cr.)
RETAIL
47.29x
1,330,000
(₹12.10 Cr.)
62,889,080
(₹572.29 Cr.)
Total
12.95x
7,315,000
94,739,520
Category
Book Size
Subscription
QIB
2.68x
3,990,000
(₹36.31 Cr.)
10,689,028
(₹97.27 Cr.)
HNI (<10 LAKH)
16.69x
665,000
(₹6.05 Cr.)
11,101,488
(₹101.02 Cr.)
HNI2 (>10 LAKH)
7.56x
1,330,000
(₹12.10 Cr.)
10,059,924
(₹91.55 Cr.)
RETAIL
47.29x
1,330,000
(₹12.10 Cr.)
62,889,080
(₹572.29 Cr.)
Total
12.95x
7,315,000
94,739,520
*Excluding Anchor
Total No. of Application Approx : ~331606 (40.89 Appwise)
HNI Cost
About Company
Incorporated in 2013, Anlon Healthcare Limited is a chemical manufacturing company engaged in manufacturing of Pharma Intermediates and active pharmaceutical ingredients (APIs).
The company manufactures high-purity pharmaceutical intermediates (for API production) and active pharmaceutical ingredients (used in formulations for medicines, nutraceuticals, personal care, and animal health products).
The company offers pharmaceutical intermediates, APIs for medicines, nutraceuticals, personal care, and veterinary products, all manufactured following Indian and international pharmacopeia standards like IP, BP, EP, JP, and USP.
In addition to manufacturing Pharma Intermediates and APIs to global standards, the company now offers custom manufacturing for complex chemicals, exceeding purity standards and reducing impurities to meet specific customer needs.
The company has received Drug Master File (DMF) approval from ANVISA, NMPA, and PMDA for loxoprofen sodium dihydrate and loxoprofen acid APIs. The company has filed 21 DMFs with global authorities and is in the process of filing for Ketoprofen and Dexketoprofen Trometamol approvals.
The company’s portfolio includes 65 commercialized products, 28 at the pilot stage, and 49 in laboratory testing.
The company ensures product quality through rigorous testing, analysis, and process improvements. Supported by four labs, the 34-member team, including 24 science graduates, ensures products meet customer and industry standards.
Products:
- Pharma Intermediates:Cyanoethylbe nzoic acid, Ketonitrile and Methyldeslor atadine, these serve as a key starting material or as an advance intermediate for manufacturing of APIs.
- Active Pharmaceutical Ingredients: The company’s APIs are key components in pharmaceutical products, delivering therapeutic effects. They are used in formulations like tablets, capsules, ointments, syrups, and in nutraceuticals, personal care, and veterinary products.
As of January 31, 2025, the company had 105 employees (excluding trainees) and 8 contract workers.
Strengths
Competitive Strengths:
- Strong product portfolio and scalable business.
- Strong Promoters and Experienced Management Team.
- High entry and exit barriers due to long customer approval cycles and strict product standards.
- In-house Testing, Quality Control and Quality Assurance for quality control.
- Focus on Quality, Environment, Health and Safety.
Company Promoters
Company Financials
| Period Ended | 31 Jan 2025 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 160.96 | 128 | 111.55 | 84.97 |
| Total Income | 77.37 | 66.69 | 113.12 | 57.54 |
| Profit After Tax | 11.96 | 9.66 | 5.82 | -0.11 |
| Net Worth | 71.86 | 21.03 | 7.37 | 1.55 |
| Reserves and Surplus | 32.01 | 5.03 | -4.63 | -10.24 |
| Total Borrowing | 62.39 | 74.56 | 66.39 | 60.32 |
| Amount in ? Crore | ||||
Objects of the Issue
The Company Anlon Healthcare IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
| S.No. | Objects of the Issue | Expected Amount (in Millions) |
|---|---|---|
| 1 | Funding capital expenditure requirements for Proposed Expansion | 3,071.95 |
| 2 | Full or part repayment and/or prepayment of certain outstanding secured borrowingssecured borrowing (term loan)availed by the Company | 500 |
| 3 | Funding the working capital requirements of the Company | 4,315 |
| 4 | General corporate purposes |
How to Apply
Apply for IPO in few simple steps.
-
Step 1
Once you create your account, Login to Easy Investing.
-
Step 2
Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.
-
Step 3
Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).
-
Step 4
Enter your UPI ID and you will receive mandate on your UPI App.
-
Step 5
Once you accept the mandate, Application is submitted successful.
The Bidding Process
- Applying for an IPO is easier than ever with Easy Investing, in just a few clicks your application is processed. You can bid for any IPO through Easy Investing, the bidding process is simple and hassle free. Every company has a lot size decided & you can buy in multiples of the decided lot.
- If lot size is 15, then you have to bid for multiples of 15 share like 30,45,60 and so on.
- The maximum subscription amount for retail investors is 2 lakh.
- Any bid can be at a desired price or cut off price given by the company.
How to bid on App?
- Enter the number of shares you wish to buy, as per the lot size.
- You can apply at the cut off price set by the company or bid for a desired amount within the price band.
- Maximum three bids will be accepted.
- You then need to enter the UPI ID on Easy Investing’s IPO application form.
Investing using UPI
- You will immediately get a fund blocked request on your UPI for the submitted IPO application.
- The funds will be blocked in your bank account until allotment when it is debited.
- The limit for IPO application is Rs 2 lakh per transaction on UPI.
- On allotment of the shares, the money will be automatically debited.
- If the share aren’t allotted the blocked funds will reflect back into your account.
FAQs
Frequently Ask Question